PhRMA On The “Defensive”: Sen. Breaux Notes Criticism Is Bipartisan

The brand name pharmaceutical industry must recognize that it is a convenient political target for members of Congress in both parties, Sen. John Breaux (D-La.) warned the Pharmaceutical Research & Manufacturers of America during the association's annual meeting April 3 in Palm Beach, Fla